Dynavax Technologies Corp.

Dynavax Technologies Corp.

Dynavax Technologies Corp.

Overview
Date Founded

2000

Headquarters

2929 SEVENTH STREET, SUITE 100, BERKELEY, CA, 94710

Type of Company

Public

Employees (Worldwide)

245

Industries

Biotechnology
Hospitals & Patient Services
Pension Funds & Sovereign Wealth
Medical Support Services

Company Description

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Contact Data
Trying to get in touch with decision makers at Dynavax Technologies Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

President & Chief Operating Officer

Chief Financial Officer & Vice President-Operations

Senior Vice President & Chief Financial Officer

Senior Vice President & General Counsel

Chief Medical Officer & Senior Vice President-Clinical Development

Chief Executive Officer, Dynavax Europe

Principal Accounting Officer & Controller

Vice President, Site Head & Managing Director

Benefit Plan Administrator

Board of Directors

Managing Director at Bain Capital LP

Former President & Chief Operating Officer at Ionis Pharmaceuticals, Inc.

Chief Executive Officer at Dynavax Technologies Corp.

Former Chief Operating Officer at Immunex Corp.

Founder at Cano Biotechnology Corp.

Chairman of the Partnership at Pure Water Inc.

Chief Executive Officer at Medical Developments International Ltd.

Chief Operating Officer & Chief Financial Officer at ReCode Therapeutics

Former Vice President-New Business & Scientific Affairs at Pfizer Vaccines LLC

Paths to Dynavax Technologies Corp.
Potential Connections via
Relationship Science
You
Dynavax Technologies Corp.
Owners & Shareholders
Details Hidden

FGIM primarily provides advice with respect to equity investment strategies; however, they do not recommend a particular type of security. The firm’s strategies include core international/emerging market equities, international equity, international small- and mid-cap equity, balanced/asset allocation, managed risk and the Kaufmann Accounts. The Kauffman strategy invests in small, mid or large-cap stocks, utilizing a fundamental bottom-up process seeking growth companies and may invest in less developed or emerging markets.

Details Hidden

Chi-Cap is an active investment manager and we use a variety of methods and strategies to make investment decisions and recommendations. In evaluating investment opportunities, the firm employs fundamental and technical research methods using various resources such as financial news sources and websites, corporate data, ratings services, third party research, SEC filings, company press releases and primary research. In choosing investments for clients, they consider a broad array of securities and investment vehicles, including common stocks, preferred stocks, master limited partnerships, corporate, government, and municipal fixed income securities, mutual funds (open-ended and exchange traded), private funds and money market funds.

Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Recent Transactions
Details Hidden

Dynavax Technologies Corp. issued USD Common Stock

Details Hidden

Dynavax Technologies Corp. issued USD Units Consisting of Common Stock and Warrants

Details Hidden

Dynavax Technologies Corp. issued USD Common Stock

Transaction Advisors
Underwriter

Advised onDynavax Technologies Corp. issued USD Common Stock

Underwriter

Advised onDynavax Technologies Corp. issued USD Common Stock

Escrow Agent

Advised onDynavax Technologies Corp. issued USD Common Stock

Managing Director Head of Equity Capital Markets, Initial Public Offerings

Advised onDynavax Technologies Corp. issued USD Common Stock

Managing Director, Investment Banking

Advised onDynavax Technologies Corp. issued USD Common Stock

Professional

Advised onDynavax Technologies Corp. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Scientific Advisor

Principal at Vaxconsult, LLC

Advisor

Former Chief Financial Officer at Dynavax Technologies Corp.

Clients

Valneva SE is a biotech company. The firm engages in the development, production and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. The Technologies and Services segment regroups services and inventions in commercialization stage. The Vaccine Candidates segment consists of proprietary research and development programs aiming to generate new approvable products. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India.

Key Stats and Financials As of 2020
Market Capitalization
$1.06B
Total Enterprise Value
$501M
Earnings Per Share
$-0.75
Revenue
$46.6M
Net Profit
$-75.2M
Total Equity
$58.7M
EBITDA
$-65.9M
EBITDAMargin
-141.54%
Total Debt
$218M
Enterprise Value / Sales
10.77x
TEVNet Income
-6.66x
Debt TEV
0.43x
Three Year Compounded Annual Growth Rate Of Revenue
422.14%
Non-Profit Donations & Grants
$5,000 - $10K
2017
$1,000 - $2,499
2017
Political Donations
$500
2002
Investments
Details Hidden

Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD.

Investors
Details Hidden

Managing Partner, Life Sciences Team at Frazier Healthcare Partners

Details Hidden

Director of the Division of Clinical Immunology at Johns Hopkins University - School of Medicine

Details Hidden

Finedix NV, part of Halisol Groupe SA, is a company headquartered in the Netherlands. The firm provides business support services.

Suppliers
Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.

GlaxoSmithKline Plc Medical Support Services | Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dynavax Technologies Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dynavax Technologies Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Dynavax Technologies Corp..